Primary Role
Board Member at Otonomy
Education
University of Illinois, Chicago

Person Details

Update

Dr. Lichter has served on Otonomy’s board of directors since May 2008. Dr. Lichter served as the company's chief executive officer from inception until November 2010. He is an experienced biotechnology and pharmaceutical business executive with 25 years of experience in management, scientific research and business development. Since 2007, Dr. Lichter has been a managing director at Avalon Ventures, an early stage venture capital fund focused on information technology and life sciences.

In that role, he led Avalon’s investments in and served as a director and chief executive officer for privately held biotechnology companies Afraxis, Inc., Carolus Therapeutics, Inc., ReVision Therapeutics, Inc. and Zacharon Pharmaceuticals, Inc. He also currently serves on the board of directors of Aratana Therapeutics, Inc., a public company.

Dr. Lichter also led Avalon’s investments in or serves on the board of privately held companies Sova Pharmaceuticals, Inc., Avelas Biosciences, Inc., COI Pharmaceuticals Inc. and Sitari Pharmaceuticals Corp.

Dr. Lichter received a doctorate and bachelor’s degree in biochemistry from the University of Illinois. He also completed post-doctoral fellowships at Yale University and Du Pont Merck Pharmaceutical Company.

Experience (16)

Update

Advisory Roles (3)

Update

Education (2)

Update